In vivo pharmacokinetic and pharmacodynamic study of co-spray-dried inhalable pirfenidone microparticles in rats

Pirfenidone (PRF) is the first FDA-approved API in the treatment of idiopathic pulmonary fibrosis (IPF). However, PRF induces serious side effects, such as photophobia and gastrointestinal disorder. PRF inhalation can be expected with a lower effective dose and reduced side effects. In this study, P...

全面介紹

Saved in:
書目詳細資料
Main Authors: Ji-Hyun Kang (Author), Min-Seok Yang (Author), Dong-Wook Kim (Author), Chun-Woong Park (Author)
格式: 圖書
出版: Taylor & Francis Group, 2022-12-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

Connect to this object online.

3rd Floor Main Library

持有資料詳情 3rd Floor Main Library
索引號: A1234.567
復印件 1 可用